This site uses cookies to provide services necessary for the operation. If you want to learn more or opt out of all or some cookies, see the cookie policy . By closing this banner, scrolling this page, clicking on consent or continuing navigation in any other way, you consent to the use of cookies Passion for Innovation. Compassion for Patients.™ Daiichi Sankyo Belgium N.V.-S.A. Show side content Location Finder Services Contact Daiichi Sankyo Websites Find Us Search Print page Contact Career Navigation About Us Who We Are Daiichi Sankyo in Europe European Strategy European Structure European Affiliates European History Global History Responsibility CSR in Europe Corporate Conduct Charter Patient Groups Sponsoring Integrity Alert Responsible Transparency Disclosure Code Belgium Disclosure Code Luxemburg Research & Development Pipeline Antithrombotic Agents R&D Network Investments Products European Products Products Belgium Products G.D. Luxembourg European Production Facilities Media European News Press Contacts Services Career Contact Daiichi Sankyo Websites Find Us Search Location Finder Recommend Page About Us Responsibility Corporate Conduct Charter Corporate Conduct Charter The Daiichi Sankyo Group fulfills its mission to "To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.“ We comply with laws, regulations and rules regarding global corporate activities, and act with the highest ethical standards and a good social conscience appropriate for a company engaged in a business that affects human lives based on the following principles. We fulfill our corporate social responsibility (CSR) by actively responding to an ever-changing society and enacting improvements for corporate value. Article 1 We diligently address medical needs by providing beneficial, safe, and reliable pharmaceuticals and services. Article 2 We conduct business in an ethical, fair and competitive manner, and maintain a healthy and professional relationship with our stakeholders, which include medical professionals and governments. Article 3 We actively communicate with our stakeholders by disclosing corporate information in a timely and appropriate manner in accordance with the principles of corporate accountability. We take appropriate measures to manage and protect personal and customer information and the confidential information of our and other companies. Article 4 The globalization of business activities requires that we operate by being compliant with the laws of each country and region, and by being respectful to all international norms including human rights, various cultures and customs. As a result, we contribute to the development of the local economy and society. Article 5 We respect diversity in the personal values, qualities and individuality of our employees, and ensure a safe and working environment that does not tolerate inappropriate treatment such as discrimination or harassment. We provide employees the opportunity to develop their skills and abilities for the mutual development of the employee and the corporation. Article 6 We responsibly manage the environmental impact of our operations as environmental issues are common challenges for mankind and such concerns are integral to our corporate activities and our very survival. Article 7 We actively engage in community activities and philanthropic programs focused on social causes. Article 8 We do not support or conduct our business with antisocial forces, prohibited entities or groups that may threaten the order or safety of civil society. Article 9 Executives of Daiichi Sankyo Group actively build and maintain effective systems to implement this Charter, ensure it is understood by all Group companies and make this Charter known to our business partners. Article 10 If the Charter is violated, Executives of Daiichi Sankyo Group Companies ensure that there is a commitment to determine the cause of infringement, take corrective action as necessary and make efforts to prevent similar violations in the future. Executives are accountable for promptly making required disclosures and upon discerning responsibility regarding the infringement, impose appropriate disciplinary action, including upon Executives themselves. Print page Contact More Stories Global CSR Far too many people around the world suffer from illnesses for which effective medicines have yet to be discovered. Providing solutions to help these people is what motivates and inspires us every day. read more... Healthy Living We are pleased to introduce nutritious Japanese recipes to enrich your set of meals by healthy food. read more… About Us Who We Are Daiichi Sankyo in Europe European Strategy European Structure European Affiliates European History Global History Responsibility CSR in Europe Corporate Conduct Charter Patient Groups Sponsoring Integrity Alert Responsible Transparency Disclosure Code Belgium Disclosure Code Luxemburg Research & Development Pipeline Antithrombotic Agents R&D Network Investments Products European Products Products Belgium Products G.D. Luxembourg European Production Facilities Media European News Press Contacts Print page Contact Copyright © Daiichi Sankyo Belgium N.V.-S.A., All rights reserved, Last Update: 12.02.2016 Site Map Disclaimer Imprint Location Finder Career Print page Contact